Drug Trial Radar · NCT00386867
A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
Last checked: Nov 20, 2026Latest source record: Jun 5, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,200
Planned (sponsor's estimate)
Start
Oct 2006
Primary completion
Not stated
Study completion Mar 2007
Sponsor
- Lead sponsor
- Gynuity Health ProjectsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 12, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This open-label, randomized study will compare the efficacy, safety, and acceptability of mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.
Conditions
- Abortion, Induced
Interventions
800 mcg misoprostol via oral or buccal administrationDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- efficacy
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Family Planning Associates Medical Group
Chicago, Illinois
Planned Parenthood League of Massachusetts (Boston clinic)
Boston, Massachusetts
Columbia University Medical Center, Division of Obstetrics & Gynecology
New York, New York
Institute for Urban Family Health
New York, New York
Parkmed
New York, New York
University of Pittsburgh, Division of Obstetrics, Gynecology and Reproductive Sciences
Pittsburgh, Pennsylvania
Whole Women's Health
Austin, Texas
Planned Parenthood
Waco, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.